Detalhe da pesquisa
1.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116523
2.
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.
Am J Hematol
; 99(3): 486-489, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174977
3.
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms.
Future Oncol
; 19(2): 103-111, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651780
4.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826241
5.
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Blood
; 134(12): 935-945, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395600
6.
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial.
Future Oncol
; 17(29): 3787-3796, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254530
7.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644114
8.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Am J Hematol
; 95(7): 749-758, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233095
9.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood
; 129(4): 424-447, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895058
10.
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.
Haematologica
; 104(6): 1168-1175, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523055
11.
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Ann Hematol
; 97(10): 1785-1795, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926156
12.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med
; 369(2): 111-21, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841729
13.
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Haematologica
; 101(1): 77-85, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26565002
14.
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.
Mycoses
; 59(9): 594-601, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27061932
15.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Haematologica
; 105(1): e13-e16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097634
16.
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).
Ann Hematol
; 94(12): 1981-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26410352
17.
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Ann Hematol
; 94(1): 23-34, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25096636
18.
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.
Am J Hematol
; 90(2): 125-31, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377359
19.
Advances in the treatment of elderly and frail patients with acute myeloid leukemia.
Curr Opin Oncol
; 26(6): 663-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25162330
20.
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.
Blood
; 119(2): 332-41, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039260